| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |